The SIR-Sphere by Sirtex is a radioactive polymer sphere that emits beta radiation and is the only FDA-approved microsphere therapy for advanced colorectal cancer that has spread to the liver.
Physicians insert a catheter through the groin into the hepatic artery and deliver millions of SIR-Sphere microspheres directly to the tumor site.
The minimally invasive procedure is performed on an outpatient basis, leaving the patient with minor side effects.
Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...
August 09, 2024 
July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...
July 31, 2024 
News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...
July 30, 2024 
July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...
July 11, 2024 
July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...
July 09, 2024 
July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...
July 05, 2024 
July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...
July 03, 2024 
July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...
July 02, 2024 
June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...
June 03, 2024 
May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...
May 30, 2024